rhproCTSD

N/A

Report date: 2025/03/20 09:13:47

Base Information

Drug NamerhproCTSD
Drug Alias Namecathepsin-Dhuman recombinant cathepsin-D (Orfoneuro)pro-cathepsin-DrhCTSDenzyme replacement therapy (Orfoneuro)
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionEnzymes modulators
TargetsEnzymes
Therapy Area/IndicationsNeuronal Ceroid-Lipofuscinoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrfoneuro ApS
China Registration ClassN/A

Develop Information

Active CompaniesOrfoneuro ApS
Inactive CompaniesN/A
Active IndicationsNeuronal Ceroid-Lipofuscinoses
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A